企業プロフィール
InMed 株価・ニュース・カタリスト
- ティッカー:
- INM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Canada and listed in the U
株価パフォーマンス
1.46 USD (-0.68%)
終値
最終更新: 2026年8月17日
5.04M USD
時価総額
株価変動の要因
As of Aug 17, 2026, INM closed down 0.68% at $1.46. No new same-company headline was identified in the current news window.
企業概要
事業概要
InMed Pharmaceuticals is a biotechnology company focused on cannabinoids and related pharmaceutical applications. Its story is centered on whether cannabinoid science can be translated into differentiated medicines.
所在地とセクター分類
InMed is headquartered in Canada and listed in the U.S. market. It sits in small-cap biotechnology with a cannabinoid focus.
ビジネスモデルの特徴
The company depends on clinical and preclinical validation, regulatory clarity, and capital efficiency. Investors usually watch early data, platform direction, and whether the company can sharpen its therapeutic thesis.
バイオ業界での位置付け
InMed occupies a niche cannabinoid biotech position. The stock is catalyst-sensitive because the company must prove both scientific and commercial relevance.
今後のカタリスト
- InMed’s catalysts are pharmaceutical-cannabinoid programs and any update that clarifies whether the company can still turn the platform into a viable development path. The market will care about human proof.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。